THANK YOU FOR SUBSCRIBING
TransplantLyfe educates and empowers the transplant community to flourish – not simply survive – after transplantation.
Fremont, CA: Lyfebulb is a digital platform that enables people living with chronic diseases to flourish by providing education, innovation, and networking. The firm bridges the gap between patient groups and the healthcare sector by working directly with patients and care partners to produce insights and implement novel solutions to decrease the burden of living with chronic disease. TransplantLyfe and IBDLyfe are the company's two internet patient communities.
"With our launch of TransplantLyfe in early 2020, Lyfebulb has been focusing more and more intently on transplantation and the diseases that precede an organ transplant. As an organ transplant recipient myself, I know first-hand the issues at hand, and the need for community, better education and most importantly, stronger commitment toward innovation to provide a better quality of life for everyone living with end-stage organ disease," said Dr. Karin Hehenberger, CEO and Founder of Lyfebulb, and Chairman of the Board of Directors. "Kevin and Mark's distinguished careers in the transplant arena will provide both strategic insights and a network of relationships to help Lyfebulb build and deliver the broad suite of services that transplant patients, centers, physicians and coordinators need to improve outcomes for people living with an organ transplant."
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Kevin Kovaleski has got appointed to the Board of Directors of Lyfebulb. In contrast, Dr. Mark Hardy, MD, Auchincloss Professor of Surgery at Columbia University has joined the firm as Chairman of Transplant Education.
Mr. Kovaleski has 25 years of pharmaceutical expertise, focusing on addressing the unmet requirements of patients with rare diseases. He most recently worked as VP and Head of Global Commercial Development for the Transplant Medicine Therapeutic Area, capping up an 18-year career in marketing and commercial operations at CSL Behring. Before joining CSL, he worked as a product manager and sales representative in the pharmaceutical industry.
Dr. Mark Hardy, Auchincloss Professor of Surgery & Director Emeritus & Founder, Transplantation Program, Columbia University Irving Medical Center, offers Lyfebulb his years of experience as a transplant physician and researcher. He was a founder member and previous President of the American Society of Transplant Surgeons and the Founding Director and Past President of the New York Organ Donor Network.
TransplantLyfe (www.transplantlyfe.com) is a digital service for transplant recipients, caregivers, and donors. It offers a secure place for interacting with people, exchanging experiences, offering tailored educational programs from major thought leaders, and keeping track of personal health facts in a private diary. TransplantLyfe educates and empowers the transplant community to flourish – not simply survive – after transplantation.
More in News